Care Capital logo

Care Capital

North America, New Jersey, United States, Princeton

Description

Care Capital, based in Princeton, New Jersey, is a specialized venture capital firm dedicated to fostering innovation within the life sciences and pharmaceutical sectors. Established in 1998, the firm has built a reputation for its deep industry expertise and strategic approach to investing in companies that are developing groundbreaking technologies and therapies. Care Capital's investment philosophy centers on identifying and supporting enterprises poised to address significant unmet medical needs, contributing to advancements in global healthcare.

The firm's investment strategy is flexible, allowing it to engage with companies across various stages of development, from nascent startups to more established entities. Care Capital typically deploys initial investments ranging from $5 million to $25 million per company, demonstrating a commitment to providing substantial capital to its portfolio firms. This initial funding is often complemented by subsequent follow-on investments, reflecting Care Capital's long-term partnership approach and belief in the sustained growth potential of its ventures. The firm manages over $500 million in capital, underscoring its significant financial capacity and established presence in the healthcare investment landscape.

Beyond financial backing, Care Capital distinguishes itself through its active engagement with portfolio companies. The firm leverages its extensive network of industry experts, scientific advisors, and strategic partners to provide invaluable operational guidance, market insights, and business development support. This hands-on approach aims to accelerate the development and commercialization of innovative solutions, helping companies navigate the complex regulatory and market challenges inherent in the life sciences industry.

Care Capital's commitment extends to cultivating a robust ecosystem where scientific breakthroughs can translate into tangible patient benefits. By focusing on areas such as biopharmaceuticals, medical devices, diagnostics, and healthcare services, the firm plays a crucial role in advancing the next generation of healthcare solutions. Its consistent track record and specialized focus position Care Capital as a key player in driving innovation and growth within the vital life sciences sector.

Investor Profile

Care Capital has backed more than 34 startups, with 0 new investments in the last 12 months alone. The firm has led 7 rounds, about 21% of its total and boasts 14 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom, Israel.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.
  • Typical check size: $5M – $25M.

Stage Focus

  • Series B (32%)
  • Series A (18%)
  • Series C (15%)
  • Series D (12%)
  • Series Unknown (12%)
  • Series E (6%)
  • Debt Financing (3%)
  • Private Equity (3%)

Country Focus

  • United States (94%)
  • United Kingdom (3%)
  • Israel (3%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Medical Device
  • Health Diagnostics
  • Biopharma
  • Women's
  • Therapeutics
  • Medical
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Care Capital frequently co-invest with?

Rho Capital Partners
North America, New York, United States, New York
Co-Investments: 4
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 3
Domain Associates
North America, California, United States, San Diego
Co-Investments: 5
MedImmune Ventures
North America, Maryland, United States, Gaithersburg
Co-Investments: 7
HealthCare Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
MV
North America, California, United States, San Diego
Co-Investments: 3
Devon Park BioVentures
North America, Pennsylvania, United States, Wayne
Co-Investments: 3
Pitango VC
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 5
Rho Ventures
North America, New York, United States, New York
Co-Investments: 12

What are some of recent deals done by Care Capital?

CoLucid Pharmaceuticals

Durham, North Carolina, United States

CoLucid Pharmaceuticals is a biotechnology company focusing on therapies for central nervous system disorders.

BiotechnologyMedical DevicePharmaceutical
Series CJan 13, 2015
Amount Raised: $37,100,000
Inotek Pharmaceuticals

Lexington, Massachusetts, United States

Inotek Pharmaceuticals develops drug candidates to address significant diseases of the eye.

BiotechnologyHealth DiagnosticsPharmaceutical
Series UnknownSep 27, 2013
Amount Raised: $21,000,000
Inotek Pharmaceuticals

Lexington, Massachusetts, United States

Inotek Pharmaceuticals develops drug candidates to address significant diseases of the eye.

BiotechnologyHealth DiagnosticsPharmaceutical
Debt FinancingSep 27, 2013
Amount Raised: $7,000,000
Agile Therapeutics

Princeton, New Jersey, United States

Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women.

BiotechnologyHealth CareWomen's
Series CJul 19, 2012
Amount Raised: $40,000,000
Elevation Pharmaceuticals

San Diego, California, United States

Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for the COPD patients.

BiopharmaBiotechnologyPharmaceutical
Series BJan 4, 2012
Amount Raised: $30,000,000
Elevation Pharmaceuticals

San Diego, California, United States

Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for the COPD patients.

BiopharmaBiotechnologyPharmaceutical
Series ASep 26, 2011
Amount Raised: $17,000,000
CoLucid Pharmaceuticals

Durham, North Carolina, United States

CoLucid Pharmaceuticals is a biotechnology company focusing on therapies for central nervous system disorders.

BiotechnologyMedical DevicePharmaceutical
Series UnknownAug 30, 2011
Amount Raised: $7,500,000
Inotek Pharmaceuticals

Lexington, Massachusetts, United States

Inotek Pharmaceuticals develops drug candidates to address significant diseases of the eye.

BiotechnologyHealth DiagnosticsPharmaceutical
Series DJul 19, 2011
Amount Raised: $23,600,000
BioCritica

Indianapolis, Indiana, United States

BioCritica develops and commercializes critical care products for the healthcare industry.

BiotechnologyLife ScienceTherapeutics
Private EquityMay 25, 2011
Amount Raised: $25,000,000
Agile Therapeutics

Princeton, New Jersey, United States

Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women.

BiotechnologyHealth CareWomen's
Series BJun 14, 2010
Amount Raised: $45,000,000